Pages that link to "Q38059028"

The following pages link to Biology of brain metastases and novel targeted therapies: time to translate the research (Q38059028):

Displaying 19 items.

• Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model. (Q27316967) (← links)
• Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial (Q27853360) (← links)
• Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis (Q30934034) (← links)
• Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors (Q34334516) (← links)
• Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors (Q35938436) (← links)
• Greater efficacy of chemotherapy plus bevacizumab compared to chemo- and targeted therapy alone on non-small cell lung cancer patients with brain metastasis (Q36772230) (← links)
• Comparison of bevacizumab plus chemotherapy with chemotherapy alone in advanced non-small-lung cancer patients (Q37152528) (← links)
• O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier (Q37432524) (← links)
• Pathogenesis of Breast Cancer Metastasis to Brain: a Comprehensive Approach to the Signaling Network (Q38281325) (← links)
• Brain metastasis: Unique challenges and open opportunities (Q39035128) (← links)
• Cooperation of neurotrophin receptor TrkB and Her2 in breast cancer cells facilitates brain metastases (Q42290389) (← links)
• Unusual acute and delayed skin reactions during and after whole-brain radiotherapy in combination with the BRAF inhibitor vemurafenib. Two case reports (Q45150448) (← links)
• AMD3100 inhibits brain-specific metastasis in lung cancer via suppressing the SDF-1/CXCR4 axis and protecting blood-brain barrier (Q47220856) (← links)
• Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. (Q47827207) (← links)
• Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma (Q59329795) (← links)
• Identification of potential biomarkers of lung adenocarcinoma brain metastases via microarray analysis of cDNA expression profiles (Q61447507) (← links)
• Perspective: The role of mechanobiology in the etiology of brain metastasis (Q63743827) (← links)
• Emerging findings into molecular mechanism of brain metastasis (Q89544565) (← links)
• Nanomaterial-based blood-brain-barrier (BBB) crossing strategies (Q90220710) (← links)